Shire PLC (LON:SHP)‘s stock had its “buy” rating restated by stock analysts at Berenberg Bank in a research report issued on Wednesday.

Several other research firms have also commented on SHP. JPMorgan Chase & Co. reiterated an “overweight” rating and issued a GBX 6,000 ($76.71) target price on shares of Shire PLC in a research note on Monday, March 27th. Liberum Capital reissued a “buy” rating and set a GBX 5,500 ($70.31) price target on shares of Shire PLC in a research report on Monday, April 10th. Jefferies Group LLC reissued a “buy” rating and set a GBX 6,600 ($84.38) price target on shares of Shire PLC in a research report on Thursday, January 5th. Citigroup Inc reissued a “buy” rating on shares of Shire PLC in a research report on Wednesday, April 12th. Finally, Credit Suisse Group AG reissued an “outperform” rating and set a GBX 5,400 ($69.04) price target on shares of Shire PLC in a research report on Wednesday, February 8th. One equities research analyst has rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of GBX 6,115.60 ($78.18).

Analyst Recommendations for Shire PLC (LON:SHP)

Shares of Shire PLC (LON:SHP) opened at 4628.50 on Wednesday. The stock’s 50 day moving average price is GBX 4,694.34 and its 200 day moving average price is GBX 4,701.68. Shire PLC has a 12 month low of GBX 2,707.19 and a 12 month high of GBX 5,377.00. The firm’s market cap is GBX 41.78 billion.

The firm also recently declared a dividend, which will be paid on Tuesday, April 25th. Investors of record on Thursday, March 9th will be paid a GBX 20.64 ($0.26) dividend. This is a boost from Shire PLC’s previous dividend of $3.51. The ex-dividend date of this dividend is Thursday, March 9th. This represents a dividend yield of 0.43%.

WARNING: This report was first reported by Watch List News and is owned by of Watch List News. If you are accessing this report on another website, it was stolen and republished in violation of United States & international trademark and copyright legislation. The legal version of this report can be viewed at

In other Shire PLC news, insider William Burns purchased 136 shares of the business’s stock in a transaction that occurred on Friday, March 31st. The shares were acquired at an average price of GBX 4,742 ($60.62) per share, for a total transaction of £6,449.12 ($8,244.85).

Shire PLC Company Profile

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.

Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.